GlassScriptPhysician profile
John W Mercer
NPI 1205988540
$12,996.09
in general payments reported to CMS, 2019-2025
13 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $9,814 · 2021: $75.82 · 2023: $1,744 · 2024: $105 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,166 · Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,166.37 |
| Food and Beverage | $828.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,669.92 | 2019-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $965.41 | 2019 | |
| Abbvie INC. | $76.41 | 2019-2021 | |
| Davol INC. | $58.24 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $51.14 | 2025 | Rexulti |
| Ethicon US, LLC | $33.23 | 2019 | |
| Organon LLC | $29.18 | 2024-2025 | Nexplanon |
| Baxter Healthcare | $28.79 | 2025 | Perclot |
| Axsome Therapeutics, INC. | $24.69 | 2025 | Auvelity |
| Millicent US INC | $17.89 | 2025 | Intrarosa |
| Minerva Surgical, INC | $15.11 | 2023 | |
| Amag Pharmaceuticals, INC. | $14.16 | 2019 | |
| Hologic Sales and Service, LLC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mercer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.